Biofrank Pharmaceuticals (India) Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 3.37%
- Profit Growth -1512.33%
- Ebitda -1013.45%
- Net Worth -995.10%
- Total Assets 28.04%
About Biofrank Pharmaceuticals (India)
Biofrank Pharmaceuticals (India) Private Limited (BPIPL) is a Private Limited Indian Non-Government Company incorporated in India on 15 October 2018 (Six years and four months 27 days old ). Its registered office is in Ambala, Haryana, India.
The Corporate was formerly known as Biofrank Pharmaceuticals Private Limited. The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Munish Manchanda and Meenakshi serve as directors at the Company.
Company Details
- Location
Ambala, Haryana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24304HR2018PTC076427
- Company No.
076427
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Oct 2018
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
FMCG
Pharma
What products or services does Biofrank Pharmaceuticals (India) Private Limited offer?
Biofrank Pharmaceuticals (India) Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Vitamin Tablets & Capsules, Ayurvedic, Herbal Oils and Cosmetics, Aloe Vera Cosmetics, Hand Sanitizers & Personal Hygiene, Face Wash, Pain Relief Drugs & Pharmaceuticals, Aceclofenac, Fitness Supplements, Flavours & Aromatics.
Who are the key members and board of directors at Biofrank Pharmaceuticals (India)?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Munish Manchanda  | Director | 15-Oct-2018 | Current |
| Meenakshi | Director | 18-May-2024 | Current |
Financial Performance of Biofrank Pharmaceuticals (India).
Biofrank Pharmaceuticals (India) Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 3.37% increase. The company also saw a substantial fall in profitability, with a 1512.33% decrease in profit. The company's net worth observed a substantial decline by a decrease of 995.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biofrank Pharmaceuticals (India)?
In 2023, Biofrank Pharmaceuticals (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Prosem Healthcare Private Limited
Munish Manchanda and Meenakshi are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Biofrank Pharmaceuticals (India)?
Unlock and access historical data on people associated with Biofrank Pharmaceuticals (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biofrank Pharmaceuticals (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biofrank Pharmaceuticals (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Biofrank Pharmaceuticals (India)
Recent activity within the organization
- Director Appointment
Meenakshi was appointed as a Director was appointed as a Director on 18 May 2024 & has been associated with this company since 9 months 23 days .
- Annual General Meeting
Biofrank Pharmaceuticals (India) Private Limited last Annual general meeting of members was held on 29 Sep 2023 as per latest MCA records.
- Balance Sheet
Biofrank Pharmaceuticals (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Delhi.
- Director Appointment
Munish Manchanda was appointed as a Director was appointed as a Director on 15 Oct 2018 & has been associated with this company since 6 years 4 months .
- Company Incorporation
Biofrank Pharmaceuticals (India) Private Limited was registered on 15 Oct 2018 with Roc Delhi & aged 6 years 4 months as per MCA records.
Frequently asked questions
What is the Incorporation or founding date of Biofrank Pharmaceuticals (India) Private Limited?
Biofrank Pharmaceuticals (India) Private Limited was incorporated on 15 Oct 2018.
What is authorized share capital and paid-up capital of Biofrank Pharmaceuticals (India) Private Limited?
The authorized share capital of Biofrank Pharmaceuticals (India) Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.
Who are the current board members & directors of Biofrank Pharmaceuticals (India) Private Limited?
Currently 2 directors are associated with Biofrank Pharmaceuticals (India) Private Limited.
- Munish Manchanda
- Meenakshi
What is the registered address of Biofrank Pharmaceuticals (India) Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Biofrank Pharmaceuticals (India) Private Limited is Shop No. 77 Jaggi Garden, Phase-2 India, Ambala City, Haryana, 134003.
What is the corporate identification number (CIN) and company number of Biofrank Pharmaceuticals (India) Private Limited?
The corporate identification number (CIN) of Biofrank Pharmaceuticals (India) Private Limited is U24304HR2018PTC076427 and the company number is 076427 as per Ministry of Corporate Affairs (MCA).
What is the official website of Biofrank Pharmaceuticals (India) Private Limited?
The Official website of Biofrank Pharmaceuticals (India) Private Limited is https://www.biofrankpharma.com
What has been the recent revenue trend for Biofrank Pharmaceuticals (India) Private Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Biofrank Pharmaceuticals (India) Private Limited has risen by 3.37%.
What change has been observed in the net worth of Biofrank Pharmaceuticals (India) Private Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Biofrank Pharmaceuticals (India) Private Limited has experienced an downturn of -995.10%.
When was the last Balance Sheet of Biofrank Pharmaceuticals (India) Private Limited filed with the ROC?
The most recent Balance Sheet for Biofrank Pharmaceuticals (India) Private Limited was filed with the ROC on 31 Mar 2023.
People also Viewed
BV
Bhanu VadhvaDirector